about
Atrial autonomic innervation: a target for interventional antiarrhythmic therapy?Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat ModelFunctional value of elytra under various stresses in the red flour beetle, Tribolium castaneumImpact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies.Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats.The nervous heart.Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats.Treating resistant hypertension: role of renal denervation.Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias.Expanding the indication spectrum: renal denervation in diabetes.Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure.The sympathetic nervous system in chronic kidney disease.Renal sympathetic denervation: applications in hypertension and beyond.Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.Renal denervation: a novel non-pharmacological approach in heart failure.Novel and nonpharmacologic approaches to cardio-protection in hypertension.Renal denervation and heart failure.Renal denervation: effects on atrial electrophysiology and arrhythmias.Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?Role of endo-epicardial dissociation of electrical activity and transmural conduction in the development of persistent atrial fibrillation.Effects of renal denervation on atrial arrhythmogenesis.Drug therapy for the patient with resistant hypertension.Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model.The importance of sleep-disordered breathing in cardiovascular disease.Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis.Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction.Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation.Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation.Progression and reversibility of stretch induced atrial remodeling: Characterization and clinical implications.Proteomic Profiling of Cardiomyocyte-Specific Cathepsin A Overexpression Links Cathepsin A to the Oxidative Stress Response.8B.04: RENAL ARTERY DENERVATION FOR TREATMENT OF HYPERTENSIVE PATIENTS WITH OR WITHOUT OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY.Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.[Sleep-disordered breathing and cardiac disease].Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction.Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation.Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry.Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
P50
Q27009311-BCB99B74-70F0-4C87-859C-99F9C7DF2F3AQ28550653-18A45288-F3F2-413E-8173-615400C0F3EFQ28597898-0FAF6C9B-7FB2-4B04-B070-438C9A6E3783Q30251913-5C757925-26DB-4966-8BFF-EE902A28C322Q30772422-586FE96A-39D7-4E88-94B8-98673F28348EQ36430309-265F7601-5CAF-4B0C-8B34-537DF9AA7FADQ36730662-9C4EA0AE-F5C6-4431-AB84-8B8307C92BC6Q36982120-F7B04D5F-E481-49D8-81A6-AFEA248623A2Q37218107-9424D0C3-6C59-49E4-8C7F-F83DE924F183Q38111569-EE1CFC97-AEF6-4581-92D2-7A4BEF18A8D3Q38111570-075FA145-D7F1-4F90-A7D7-DD5EC90EE01EQ38111571-355FAFC7-AEA2-4DF7-AF50-AB88EDAFE578Q38112066-F530A837-A0D1-4ACF-8E16-A4368070422AQ38115114-07B6E203-010B-4056-998D-73B8F8F6B7C5Q38181036-B7EA73A5-5361-4768-B8BB-A0FCDB2F7333Q38191875-000AE1BF-F457-4FA0-A58F-518BB5F0325BQ38196355-34243A55-C0CD-48F7-97B8-CA3488F74E3DQ38197134-48E9A5F8-31B2-4817-A81F-3734DAC09EA2Q38200501-24EE6072-F031-4C50-97DD-7A045373C6BCQ38230820-C75D2FD1-FFFC-4D48-AE99-D7BC4B8758FCQ38236256-6BEE64E2-831D-40B3-B894-DE82A703106AQ38286295-3394862A-AA5D-4D05-ADF6-35EF00105E07Q38373858-33740859-8B6A-4DAE-9FA5-AF90513C7F70Q38412937-831FA7EF-381C-4BF9-B2DA-00FF41F72615Q38436072-29BF52CB-EAB1-4E23-809F-59D6BAE7AE09Q38671375-6FBE8F29-EF57-4C75-8365-BDFD9EB179E0Q38849684-EF5478B6-09C2-4BCC-92B9-E68B0342A379Q38951792-01B116D2-552A-4510-B7EF-4E0AA709010EQ39421654-9F3C0C31-B7E1-410F-8E34-5ADE8F3B2ACEQ39452172-20CD38A9-CF3A-411B-AB1A-211C0ABD0F9FQ39587092-29ED4255-5005-4DF2-8E28-4F38FBE91693Q40808260-B09F48ED-D48E-4A45-BFC0-B38A1CE0C6A0Q40908969-6FA5145B-231F-4DE5-88C0-F0753B9528BFQ41453645-15F7A6B0-8864-419D-AFA2-2F72425ED3E6Q44169580-DDF836D2-0B32-4340-A15E-FE760499D72DQ44898822-15E151D9-D171-4C7B-8826-F7E7BA0C254BQ45058890-F38F6809-54A0-4CA9-8EA0-C4CF2D53251DQ46231863-368B4BBD-FFFC-4667-8FAD-06690A9C94ADQ46306396-86EFCEE0-2EDF-412D-9595-C254A1BF8B0EQ46558328-B74CC09B-19BE-46CE-9337-6677C36157B9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dominik Linz
@ast
Dominik Linz
@en
Dominik Linz
@es
Dominik Linz
@nl
Dominik Linz
@sl
type
label
Dominik Linz
@ast
Dominik Linz
@en
Dominik Linz
@es
Dominik Linz
@nl
Dominik Linz
@sl
prefLabel
Dominik Linz
@ast
Dominik Linz
@en
Dominik Linz
@es
Dominik Linz
@nl
Dominik Linz
@sl
P106
P31
P496
0000-0003-4893-0824